You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Mefoxin In Sodium Chloride 0.9% In Plastic Container, and what generic alternatives are available?

Mefoxin In Sodium Chloride 0.9% In Plastic Container is a drug marketed by Merck and is included in one NDA.

The generic ingredient in MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is cefoxitin sodium. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.

Summary for MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Drug patent expirations by year for MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Recent Clinical Trials for MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Bristol-Myers SquibbN/A
University of KwaZuluN/A

See all MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

US Patents and Regulatory Information for MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cefoxitin sodium INJECTABLE;INJECTION 050581-002 Sep 20, 1984 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Merck MEFOXIN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER cefoxitin sodium INJECTABLE;INJECTION 050581-001 Sep 20, 1984 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.